Next Article in Journal
Posttraumatic Stress Disorder and Adjustment Disorder in Lithuanian Healthcare in 2018–2020: A Nation-Wide Cohort Study of the Effects of COVID-19 Pandemic
Next Article in Special Issue
Lifetime Major Discrimination Experiences Moderate the Impact of Depressive Symptoms on Chronic Conditions among Black Americans
Previous Article in Journal
Development of an Online Asynchronous Clinical Learning Resource (“Ask the Expert”) in Dental Education to Promote Personalized Learning
Previous Article in Special Issue
Racism, Chronic Disease, and Mental Health: Time to Change Our Racialized System of Second-Class Care
Review

Disparities across Diverse Populations in the Health and Treatment of Patients with Osteoarthritis

1
Medical Affairs, Internal Medicine, Pfizer Inc., 235 E. 42nd Street New York, New York, NY 10017, USA
2
Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Shelley White-Means and Altha J. Stewart
Healthcare 2021, 9(11), 1421; https://doi.org/10.3390/healthcare9111421
Received: 30 August 2021 / Revised: 8 October 2021 / Accepted: 11 October 2021 / Published: 22 October 2021
The study of disparities across diverse populations regarding the health and treatment of patients with osteoarthritis (OA) is recognized as a priority for investigation and action by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the American Academy of Orthopedic Surgeons (AAOS). OA is a common condition that increases with age, but with prevalence generally similar across racial and ethnic groups. However, disparities in the treatment of OA among racial, ethnic, and socioeconomic groups are well-documented and continue to rise and persist. The reasons are complex, likely involving a combination of patient, provider, and healthcare system factors. Treatment disparities among these different populations have an impact on clinical outcomes, healthcare, and productivity, and are projected to increase significantly with the growing diversity of the United States population. The aim of this short review is to summarize studies of racial, ethnic, and socioeconomic disparities among patients with OA in the United States, with a focus on prevalence, treatment utilization, and clinical and economic outcomes. View Full-Text
Keywords: osteoarthritis; disparities; racial; ethnic; prevalence; treatment utilization; clinical outcomes; economic outcomes osteoarthritis; disparities; racial; ethnic; prevalence; treatment utilization; clinical outcomes; economic outcomes
Show Figures

Figure 1

MDPI and ACS Style

Faison, W.E.; Harrell, P.G.; Semel, D. Disparities across Diverse Populations in the Health and Treatment of Patients with Osteoarthritis. Healthcare 2021, 9, 1421. https://doi.org/10.3390/healthcare9111421

AMA Style

Faison WE, Harrell PG, Semel D. Disparities across Diverse Populations in the Health and Treatment of Patients with Osteoarthritis. Healthcare. 2021; 9(11):1421. https://doi.org/10.3390/healthcare9111421

Chicago/Turabian Style

Faison, Warachal E., P. G. Harrell, and David Semel. 2021. "Disparities across Diverse Populations in the Health and Treatment of Patients with Osteoarthritis" Healthcare 9, no. 11: 1421. https://doi.org/10.3390/healthcare9111421

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop